170 related articles for article (PubMed ID: 23580381)
21. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Centonze D; Bari M; Rossi S; Prosperetti C; Furlan R; Fezza F; De Chiara V; Battistini L; Bernardi G; Bernardini S; Martino G; Maccarrone M
Brain; 2007 Oct; 130(Pt 10):2543-53. PubMed ID: 17626034
[TBL] [Abstract][Full Text] [Related]
22. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
23. Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.
Bassir Nia A; Gibson CL; Spriggs SA; Jankowski SE; DeFrancisco D; Swift A; Perkel C; Galynker I; Honrao C; Makriyannis A; Hurd YL
J Psychopharmacol; 2023 May; 37(5):484-489. PubMed ID: 36633290
[TBL] [Abstract][Full Text] [Related]
24. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis.
Mechoulam R; Ben-Shabat S
Nat Prod Rep; 1999 Apr; 16(2):131-43. PubMed ID: 10331283
[No Abstract] [Full Text] [Related]
25. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
Suplita RL; Gutierrez T; Fegley D; Piomelli D; Hohmann AG
Neuropharmacology; 2006 Mar; 50(3):372-9. PubMed ID: 16316669
[TBL] [Abstract][Full Text] [Related]
26. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Leweke FM; Piomelli D; Pahlisch F; Muhl D; Gerth CW; Hoyer C; Klosterkötter J; Hellmich M; Koethe D
Transl Psychiatry; 2012 Mar; 2(3):e94. PubMed ID: 22832859
[TBL] [Abstract][Full Text] [Related]
29. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.
Kranaster L; Hoyer C; Aksay SS; Bumb JM; Leweke FM; Janke C; Thiel M; Lutz B; Bindila L; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):781-786. PubMed ID: 28342110
[TBL] [Abstract][Full Text] [Related]
30. Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid.
Koethe D; Schreiber D; Giuffrida A; Mauss C; Faulhaber J; Heydenreich B; Hellmich M; Graf R; Klosterkötter J; Piomelli D; Leweke FM
J Neural Transm (Vienna); 2009 Mar; 116(3):301-5. PubMed ID: 19137236
[TBL] [Abstract][Full Text] [Related]
31. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
32. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
34. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
35. Oxygenation of Anandamide by Lipoxygenases.
van Zadelhoff G; van der Stelt M
Methods Mol Biol; 2016; 1412():217-25. PubMed ID: 27245907
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
37. Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices.
Sarmad S; Alexander SP; Barrett DA; Marsden CA; Kendall DA
J Neurochem; 2011 May; 117(4):665-77. PubMed ID: 21375532
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Manduca A; Morena M; Campolongo P; Servadio M; Palmery M; Trabace L; Hill MN; Vanderschuren LJ; Cuomo V; Trezza V
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1362-74. PubMed ID: 25914159
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
[TBL] [Abstract][Full Text] [Related]
40. CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study.
Romigi A; Bari M; Liguori C; Izzi F; Rapino C; Nuccetelli M; Battista N; Bernardini S; Centonze D; Mercuri NB; Placidi F; Maccarrone M
CNS Neurol Disord Drug Targets; 2020; 19(2):142-147. PubMed ID: 32148204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
